Sutro Biopharma (STRO) Revenue Growth (1y) (2018 - 2025)
Sutro Biopharma (STRO) Revenue Growth (1y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 35.46% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 7.82% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.04% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 64.03% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Sutro Biopharma | 202.59 Mn | 61.16 Mn | - | -55.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -55.43% |
| Sep 30, 2025 | 13.77% |
| Jun 30, 2025 | 147.98% |
| Mar 31, 2025 | 33.76% |
| Dec 31, 2024 | -86.98% |
| Sep 30, 2024 | -49.66% |
| Jun 30, 2024 | 146.89% |
| Mar 31, 2024 | 2.64% |
| Dec 31, 2023 | 1,217.44% |
| Sep 30, 2023 | -32.70% |
| Jun 30, 2023 | -62.94% |
| Mar 31, 2023 | 114.92% |
| Dec 31, 2022 | -18.98% |
| Sep 30, 2022 | 195.26% |
| Jun 30, 2022 | 0.17% |
| Mar 31, 2022 | -59.77% |
| Dec 31, 2021 | 28.70% |
| Sep 30, 2021 | -52.21% |
| Jun 30, 2021 | 196.22% |
| Mar 31, 2021 | 104.98% |